MENTAL HEALTH & SUBSTANCE ABUSE SERVICES, TENNESSEE DEPARTMENT OF: $95.1M Department of Health and Human Services Grant
Summary
This $95.1M grant to the Tennessee Department of Mental Health and Substance Abuse Services funds opioid and stimulant use disorder prevention, treatment, and recovery programs across the state. As the recipient is a state agency, no publicly traded company is directly tied to this award, but the overall sector impact supports healthcare service providers and harm reduction supply vendors.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The contract is a state-level grant, not awarded to a public company, so no direct stock impact.
- 2.Federal opioid response funding continues at significant levels, supporting healthcare sector tailwinds.
- 3.Investors should monitor companies involved in naloxone, buprenorphine, and addiction treatment services for indirect benefits.
Market Implications
Since the recipient is a state agency, there is no direct market implication from this specific award. Broader sentiment for healthcare companies focused on substance use disorder treatments may be supported, but this contract alone does not move markets. Investors should look for contracts awarded directly to public companies in the behavioral health space, such as Acadia Healthcare or Universal Health Services, for clearer catalysts.
Full Analysis
The contract is a $95.1M project grant from SAMHSA to the Tennessee Department of Mental Health and Substance Abuse Services (TDMHSAS) for the TN SOR IV initiative, running from September 2024 to September 2027. The funding targets the opioid epidemic through expanded access to medication for opioid use disorder (MOUD), naloxone distribution, prevention training, and pilot programs for emergency department-initiated buprenorphine/naloxone and low-barrier MAT. Since the recipient is a state government entity, there is no direct public company beneficiary to attribute revenue impact. However, the award signals continued federal commitment to combating the opioid crisis, which benefits healthcare service providers, behavioral health companies, and pharmaceutical manufacturers of naloxone and buprenorphine products. Among related legislation, the 'Work Without Worry Act of 2026' (S5006) is neutral with impact 1/10 in Healthcare sector, indicating low legislative tailwind. No supply chain winners are identifiable from the contract description, as the grant flows through state-operated programs. Historically, similar SAMHSA state opioid response grants have supported steady funding for community health centers and medication-assisted treatment providers, but without direct stock price impact.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
MICHIGAN DEPARTMENT OF HEALTH AND HUMAN SERVICES: $111M Department of Health and Human Services Grant
MARYLAND DEPARTMENT OF HEALTH: $162M Department of Health and Human Services Grant
HEALTH CARE AUTHORITY: $82.7M Department of Health and Human Services Grant
PENNSYLVANIA DEPARTMENT OF DRUG AND ALCOHOL PROGRAMS: $253M Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Contract Details
Recipient
MENTAL HEALTH & SUBSTANCE ABUSE SERVICES, TENNESSEE DEPARTMENT OF
Award Amount
$95,091,791
Awarding Agency
Department of Health and Human Services
Sub-Agency
Substance Abuse and Mental Health Services Administration
Contract Type
PROJECT GRANT (B)
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →